In prostate cancer, TGF‐β inhibits proliferation by prevention of G1 progression in early stages of prostate cancer cells via suppressing Cyclin D1 mRNA and protein expression (Figure 4I). This evidence concerns the gene CCND1 and Familial prostate cancer.